Clincosm LogoSign in Get a demo

Correlation Between ADR of Screening and All Colonoscopies

Sponsor
Hospital Frydek-Mistek (Other)
Overall Status
Completed
CT.gov ID
NCT03730441
Collaborator
(none)
6,925
Enrollment
1
Location
59
Actual Duration (Months)
117.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of the study is to compare ADR for colonoscopies from various indications and to find correlations between ADR of screening and all examinations.

Condition or Disease Intervention/Treatment Phase
  • Device: Colonoscopy

Detailed Description

ADR (adenoma detection rate) is generally accepted quality indicator and it is calculated from screening colonoscopies in patients over 50 years of age. For possible gaming with ADR for screening colonoscopies, monitoring of ADR for all colonoscopies is discussed nowadays.The aim of the study is to compare ADR for colonoscopies from various indications and to find correlations between ADR of screening and all examinations.

We want to retrospectively assess the quality indicators of all colonoscopies performed from January 2013 to December 2017. We want to calculate ADR for all colonoscopies in patients over 50 years of age excluding therapeutic, IBD, management of complications and sigmoidoscopies (screening, surveillance, diagnostic) and separately only for screening colonoscopies. Correlation analysis will be performed using Pearson´s correlation coefficient.

Study Design

Study Type:
Observational
Actual Enrollment :
6925 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Correlation Between ADR of Screening and All Colonoscopies
Actual Study Start Date :
Jan 1, 2013
Actual Primary Completion Date :
Dec 1, 2017
Actual Study Completion Date :
Dec 1, 2017

Outcome Measures

Primary Outcome Measures

  1. correlation between ADR of screening and all colonoscopies (screening, surveillance, diagnostic) [january 2013 - december 2017]

    Pearson´s correlation coefficient

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • people over 50 years of age coming for colonoscopic examination (screening, surveillance, diagnostic)
Exclusion Criteria:

  • age under 50 years

  • indication for colonoscopy: therapeutic, IBD, management of complications and sigmoidoscopies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hospital Frydek-Mistek Frýdek-Místek Czechia

Sponsors and Collaborators

  • Hospital Frydek-Mistek

Investigators

  • Principal Investigator: Ivana Mikoviny Kajzrlikova, Doctor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ivana Mikoviny Kajzrlikova, MD, PhD, MD, Hospital Frydek-Mistek
ClinicalTrials.gov Identifier:
NCT03730441
Other Study ID Numbers:
  • ADR
First Posted:
Nov 5, 2018
Last Update Posted:
Nov 5, 2018
Last Verified:
Nov 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Colonic Neoplasms

Study Results

No Results Posted as of Nov 5, 2018